Common questions about Labella (FAQ)
Q: Is Labella the same kind of medicine as [similar common drug]? What's the difference?
A: According to official product information, Labella is a combination oral contraceptive (COC). It contains two synthetic hormones, levonorgestrel (a progestin) and ethinyl estradiol (an estrogen), which work together to prevent pregnancy. Its classification as a COC puts it in the same group as other combined hormone contraceptives.
Q: How quickly should I expect to see an effect from Labella?
A: Official documents describe that for Labella to prevent pregnancy, a non-hormonal back-up method is generally noted as necessary until an active tablet has been taken daily for 7 consecutive days. Contraceptive effectiveness is noted to be established after this initial period, according to prescribing guidelines.
Q: What is the typical time frame for the full effect of Labella to be reached?
A: The required time for contraceptive effectiveness to be established is seven consecutive days of active tablet use. While clinical trials may follow participants for longer to evaluate the drug's full effects, the initial period for pregnancy prevention is consistently noted in official prescribing information.
Q: Does Labella interact with herbal supplements like St. John's Wort?
A: Regulatory documents state that certain medicines or herbal products classified as enzyme inducers may decrease the effectiveness of Labella. This group includes supplements like St. John's Wort. Official information describes that a back-up or alternative method of contraception is noted as necessary when these substances are taken together.
Q: Can Labella be used during pregnancy?
A: Labella is not indicated for use during pregnancy. Regulatory documents describe that if pregnancy is confirmed or suspected, the medication is noted as needing to be discontinued.
Q: What should I do if a side effect is bothering me?
A: The official safety profile provides a clear, categorical distinction between common, non-serious effects and rare, but clinically significant risks. For common, expected effects like irregular bleeding, official information notes that they often diminish within the first three months of use. The Instructions for Use contain information about side effects and general steps related to the drug's use.
Q: Why do some people stop using Labella?
A: Studies have noted that common reasons cited for discontinuing combined oral contraceptives in clinical settings may include experiences with side effects such as bleeding irregularities (spotting), mood changes, and decreased sexual desire.
Q: Is Labella safe for people with high blood pressure?
A: Regulatory documents state that Labella is contraindicated in females with uncontrolled hypertension (high blood pressure) or high blood pressure complicated by vascular disease. For individuals with well-controlled hypertension, the regulatory label indicates that careful monitoring of blood pressure is noted.
Q: Can children or teenagers use Labella?
A: Labella is indicated for use by females of reproductive potential to prevent pregnancy. Official documentation states that the safety and efficacy have been established in this population, which includes post-menarcheal adolescents (those who have started their menstrual cycles).
Q: Are there any foods or drinks I should avoid while using Labella?
A: Official drug information notes that Grapefruit or grapefruit juice may increase the blood levels of the components in Labella by affecting how they are processed by the body. The official information indicates that patients who regularly consume grapefruit may require monitoring.
Q: Is Labella a treatment that I have to take long-term?
A: Labella is indicated for the continuous, ongoing prevention of pregnancy in females of reproductive potential. Regulatory guidelines do not specify a maximum duration for this continuous use.
Q: If Labella is working, what should I generally notice?
A: The primary purpose of the medication is to prevent pregnancy (anovulation). Additionally, the use of Labella is designed to result in a predictable scheduled withdrawal bleed during the non-hormonal days of the cycle.
Q: Are there different strengths or versions of Labella available?
A: The active ingredients in Labella (levonorgestrel and ethinyl estradiol) are found in regulatory documents in a variety of dose strengths and different cycle regimens. These can include cycles with different ratios of active pills to inactive pills, such as 21/7 day or 84/7 day continuous dose options.
Q: Are there warnings about using Labella for people with liver problems?
A: Regulatory documentation states that Labella is contraindicated in females with conditions such as liver tumors, acute viral hepatitis, or severe cirrhosis. The official information also advises that the medication is noted as needing to be discontinued if jaundice (yellowing of the skin or eyes) occurs.
Q: Do older adults (seniors) need a different approach to using Labella?
A: The regulatory label highlights a significantly increased risk of serious cardiovascular events in females over 35 years of age who smoke. Official prescribing information describes that consideration of cardiovascular risk factors may be relevant, particularly in those over 35.
Q: Is Labella an addictive medicine?
A: Labella is not classified as a controlled substance under federal regulation. According to the official documentation, there are no reports of abuse or dependency associated with this medication.
Q: Why is Labella not used for [condition outside its approved use]?
A: Labella is regulated solely for its approved indication, which is the prevention of pregnancy in females of reproductive potential. The official documentation does not address or endorse its use for any non-approved conditions.
Q: Can people with kidney disease use Labella?
A: Regulatory information notes that combined oral contraceptives may cause some degree of fluid retention. The regulatory label indicates that the medication's potential to cause fluid retention suggests it should be used with caution and monitoring in patients with conditions such as renal dysfunction (kidney problems) that might be affected by fluid retention.
Q: What are the most common reasons a doctor might prescribe Labella?
A: The only FDA-approved reason for prescribing Labella is the prevention of pregnancy in females of reproductive potential. Prescribing decisions are made based on the approved use and a patient's individual needs.
Q: Is Labella available as a generic drug?
A: The combination of active ingredients in Labella, levonorgestrel and ethinyl estradiol, is manufactured and available through several companies under multiple generic and brand names. Generics contain the same active ingredients in the same dosage form.
Q: Can men use Labella?
A: Labella is regulated and indicated solely for use by females of reproductive potential to prevent pregnancy. Official documents do not support its use by men.
Q: Is the name Labella the brand name or the drug ingredient name?
A: Labella is the brand (trade) name for the drug. The active drug ingredients are the synthetic hormones levonorgestrel and ethinyl estradiol.
Q: Do studies suggest Labella helps with [specific vague symptom of the treated condition]?
A: Studies cited in regulatory submissions explored this treatment’s association with the severity and frequency of flare-ups and evaluated changes in participant symptoms over time. Findings are summarized in the research overview section of the drug information.
Q: Is Labella a new medicine or has it been around for a long time?
A: The active drug ingredients in Labella, levonorgestrel and ethinyl estradiol, are components of a class of medicines that have been regulated and in use for many decades. The specific formulation of Labella would have its own date of regulatory approval.
Q: Can Labella be used by people with a history of depression?
A: Official warnings note that females with a history of depression should be carefully observed while using the medication. Discontinuation of the drug is noted in official warnings if depression recurs to a serious degree. Depressed mood is also listed as a common adverse reaction in official safety profiles.
